A gene with substantial sequence similarity to the mreB morphogene of Bacillus subtilis has been identified at 302؇ on the chromosomal map by A. Decatur, B. Kunkel, and R. Losick (Harvard University; personal communication). Our characterization has revealed that the protein product of this determinant (termed mbl for mreB-like) is 55 and 53% identical in sequence to the MreB proteins of B. subtilis and Escherichia coli, respectively. The protein is 86% identical to a protein identified as MreB from Bacillus cereus, suggesting that the B. cereus protein is actually Mbl. Insertional inactivation of mbl indicated that this gene is not essential for cell viability or sporulation. Cells bearing mutant mbl alleles display a decreased growth rate and an altered cellular morphology. The cells appear bloated and are frequently twisted. Intergenic suppressor mutations which restore the growth rate to an approximately normal level arise within the mutant population. A second site mutation, designated som-1, was mapped to the hisA-mbl region of the chromosome by transduction.
The mre operon of Escherichia coli consists of five genes, mreBCD, orfE, and cafA (10, 25, (33) (34) (35) (36) . The mreBCD genes are associated with cell shape determination and sensitivity to the aminidopenicillin mecillinam. A point mutation within mreB or a deletion of mreBCD results in a morphological shift in the cell population with the formation of spherical cells. The mreB determinant encodes a 37,000-kDa protein which shows significant sequence similarity to the DnaK protein, as well as to other members of the Hsp70 superfamily, and to the FtsA cell division-associated protein (3, 13) . Inactivation of the MreB protein results in an increased level of the FtsI protein, the septation-specific penicillin-binding protein 3 (36) . The increased FtsI presumably results in hyperseptation activity and hence spherical-cell formation (22) . The introduction of mreB on a multicopy plasmid results in the cells becoming filamentous and an accompanying decrease in FtsI (36) . On the basis of these observations, Wachi et al. have postulated that the MreB protein acts as a negative regulator of FtsI (36) .
The MreB homolog of Bacillus subtilis is contained within the divIVB minicell operon (19, 20, 32) . This operon contains the mreBCD determinants as well as the minCD minicell-associated genes. Immediately upstream of divIVB lies maf, the apparent homolog of orfE of the E. coli mre operon (5) . The B. subtilis MreB protein has substantial amino acid sequence similarity (56.8% identity, 67% similarity) with its E. coli counterpart. A difference between the E. coli and B. subtilis mreB determinants with regard to inactivation has been noted. Loss of MreB function in E. coli results in viable spherical cells, whereas attempts to inactivate the mreB determinant of B. subtilis have been unsuccessful (20, 32) . MreB function is apparently required for the maintenance of cell viability in this gram-positive bacterium.
The mreB determinant of B. subtilis was identified by amino acid sequence similarity between its product and the MreB protein of E. coli as well as its position immediately upstream of the mreCD determinants. A second determinant encoding a protein with substantial sequence similarity to E. coli MreB was identified by Decatur et al. immediately downstream of the spoIIID determinant (8, 18) . The possession of a second mreBlike determinant by B. subtilis is especially intriguing, given that the mreB determinant is apparently an essential determinant for this bacterium. The spoIIID-distal determinant, mbl (for mreB-like), was brought to our attention by R. Losick and is further characterized in this report.
MATERIALS AND METHODS
Bacterial strains and plasmids. Bacterial strains and plasmids utilized in this study are presented in Table 1 . Plasmid pBK32, which contains a 4-kb Sau3A-to-SacI B. subtilis DNA fragment bearing spoIIID and mbl, was generously provided by R. Losick (Harvard University) (4, 18) . To obtain chromosomal DNA extending beyond the SacI site, the 1.2-kb PstI-to-SacI fragment bearing the 3Ј end of mbl ( Fig. 1 ) was subcloned into pUC18. A chloramphenicol acetyltransferase (cat) cassette (26) was inserted at the EcoRI site of the plasmid to provide selection in B. subtilis host cells. The plasmid was transformed into B. subtilis 168 competent cells. Chloramphenicol-resistant (Cm r ) cells arise because of the integration of the plasmid into the chromosome by virtue of the homology provided by the PstI-SacI insert. Chromosomal DNA was isolated from a Cm r clone. The DNA was cleaved with EcoRI, ligated under dilute conditions to favor intramolecular ligation, and transformed into E. coli strain HB101 with selection for pUC18's ampicillin resistance. The resulting plasmid, pYA2273, contains a 2.7-kb PstI-to-EcoRI insert which includes part of the mbl determinant as well as orfF and orfG. Plasmid pYA2280 was constructed by insertion of a 2.3-kb HindIII fragment bearing the 5Ј end of mbl and spoIIID (from pBK32) into the HindIII site of pYA2273 (with loss of pYA2273's HindIII fragment). The plasmid pYA2280 thus contains an intact region of the B. subtilis chromosome bearing spoIIID, mbl, and the downstream orfs.
General methods. Media and growth conditions, including antibiotic concentrations, used for propagation and selection of E. coli and B. subtilis were as described previously (16) . Transduction with PBS1 was as described elsewhere (6) . Competent E. coli and B. subtilis cells were prepared and transformed as described by Dagert and Ehrlich and by Erickson and Copeland, respectively (7, 11) . B. subtilis chromosomal DNA was isolated according to the procedure of Saito and Miura (27) . Plasmid DNA from E. coli was prepared by the alkaline lysate procedure of Birnboim and Doly (2) .
DNA hybridization. Preparation of radiolabeled DNA probes, Southern blotting of DNA, and hybridization conditions were as previously described (16) .
DNA sequencing. DNA sequencing was done by the dideoxy chain termination method of Sanger et al. (28) with the Sequenase sequencing kit (U.S. Biochemical Corp.). DNA fragments were subcloned into the phage vectors M13mp18 and M13mp19 for single-stranded sequencing. Some sequence determinations utilized primers obtained from the University of South Carolina Oligonucleotide Synthesis Facility. Both DNA strands were completely sequenced. Preliminary sequence data consisting of 500 bases extending from the DraIII site, which includes the 5Ј end of mbl, were provided by R. Losick. Amino acid sequence comparisons were carried out through the BLAST Network Service of the National Center for Biotechnology Information (1).
Photomicrography. Bacterial cells for photomicrography were first washed in saline and fixed in 0.5% glutaraldehyde for 5 min at room temperature. Volumes (6 l) were transferred to slides previously coated with poly-L-lysine, and phasecontrast micrographs were taken with Kodak TMY-400 film.
B. subtilis cells for transmission electron microscopy were prepared as previously described (5) . The bacterial cells were infiltrated with LR white resin, and thin sections were prepared. Sections were examined with a JEOL JEM-100CXII transmission electron microscope.
Construction of mbl-lacZ fusions. In-frame fusions were generated by ligation of the mbl fragment at its EcoRV site to the E. coli lacZ determinant of plasmid pMLB1034 (29) at its SmaI site. The fusion thus consists of the first 160 codons of mbl followed by two codons contributed by the pMLB1034 linker and then the lacZ determinant beginning with the ninth codon. All the fusion constructs share the EcoRV-SmaI junction but differ in the extent of sequences upstream of mbl. The inserted fragments, in order of increasing size, were DraIII-EcoRV (525 bp), which contains the mbl ribosome binding site but lacks its putative promoter sequence; DraI-EcoRV (1 kb), which contains all of the spoIIID coding sequence but is without its promoter (30) ; HindIII-EcoRV (1.8 kb), which contains all of spoIIID; and EcoRV-EcoRV (2.2 kb), which contains all of spoIIID and 400 bp of additional upstream sequences. The fusion constructs were subcloned into the amyE integration vector pDG364, constructed by P. Straiger (6, 12) . The pMC1034 constructs were cleaved with EcoRI and ScaI, and the large fragment liberated was cloned into pDG364 which had been cleaved with HindIII; this end was made blunt ended with Klenow fragment of DNA polymerase I and then cleaved with EcoRI. The plasmid clones were then transformed into B. subtilis MO1099 (amyE::erm), and strains bearing a single copy of the fusion were selected as being Cm r and sensitive to erythromycin. Measurement of ␤-galactosidase activity. ␤-Galactosidase activity was determined with the substrate o-nitrophenyl-␤-D-galactopyranoside (ONPG) by the method of Miller (23) .
Nucleotide sequence accession number. The nucleotide sequence of mbl, orfF, and the 5Ј end of orfG has been deposited with GenBank under accession number U12962.
RESULTS
Nucleotide sequence analysis of mbl. The mbl region of the B. subtilis chromosome is immediately distal to spoIIID and is depicted in Fig. 1 . The mbl open reading frame consists of 333 codons followed by an opal stop codon and is preceded by a ribosome binding site (AAGGAGG) . The open reading frame is followed (7 bp after the stop codon) by a region of dyad symmetry. When transcribed, this would give rise to a potential (38) . OrfF is identical to the B. subtilis FlgG protein at 24.6% of the positions and has a similarity value of 38.3%. The identity and similarity values when OrfF is aligned with FlgG of S. typhimurium are 15 and 26.5%, respectively. A conserved sequence is found near the N terminus of the flagellar rod proteins (13, 38) . This domain has the consensus sequence A/SNNI/LAN, and it is also present in OrfF (SNNIAN, residues 24 to 29).
Immediately downstream of orfF is another open reading frame, for which we have determined the sequence of the first 135 codons. This putative determinant has been designated orfG. The deduced amino acid sequence of the orfG product reveals a polypeptide with a high content of glutamine residues (14 of 135 [10.3%] ). In addition, there are 9 aspartic acid residues. The distribution of charged residues in this protein results in the presence of distinct positively and negatively charged domains. The OrfG polypeptide, like OrfF, shows sequence similarity with the B. subtilis FlgG protein. The first 47 residues of the OrfG and FlgG proteins are identical at 16 positions (34%) and similar at 28 positions (52%). The similarity between OrfG and S. typhimurium FlgG over the Nterminal 58 residues includes 32% identity and 56% similarity. The greatest similarity value obtained with OrfG was with a flagellar hook polypeptide from Treponema phagedenis (21) . Comparison of these two polypeptides gave values of 32% identity and 53% similarity over a window of the N-terminal 76 residues.
Inactivation of the orfF determinant. Because of the sequence similarity of the OrfF polypeptide with flagellum components, the orfF determinant was inactivated to determine whether it functions in motility of B. subtilis. The orfF open reading frame was interrupted by the insertion of a cat cassette at the SacI site. The cat-interrupted allele was crossed into the chromosome, creating strain KUS1160. To verify that the Cm r strains which arose were due to an allele exchange and not due to Campbell insertion of the plasmid bearing orfF::cat, Southern blot hybridization analysis was carried out. PstI-digested chromosomal DNAs from three Cm r transformants were electrophoresed in a 0.8% agarose gel, Southern transferred to a nitrocellulose filter, and probed with pYA2278 (which bears the 600-bp PstI-to-HindIII mbl-containing fragment). If the allele exchange had occurred correctly in these strains, the probe should reveal a single band of 2.5 kb, representing the 1.7-kb mbl-orfF fragment containing the 800-bp cat cassette. If Campbell insertion had occurred, resulting in the cells bearing both a wild-type allele of orfF and the orfF::cat allele, three bands, of 1.7, 2.5, and 5.5 kb, would be expected. As can be seen in Fig. 3B , lanes 2 to 4, these strains contain only the orfF::cat allele. However, phase-contrast-microscopic examination of these strains revealed that they remained motile, indicating that orfF is not required for motility of B. subtilis.
Creation of mbl mutants of B. subtilis. Previous attempts to inactivate the B. subtilis mreB determinant have been unsuccessful. Given the remarkable sequence similarity between mreB and mbl, it was of interest to inactivate mbl and examine the mutants for growth and morphological defects. The plasmids pYA2287 and pYA2242 were created; they consist of a 2.3-kb HindIII fragment bearing most of mbl inserted into a pUC18 derivative lacking its polylinker PstI site and of the 1-kb PstI-SacI mbl fragment inserted into pUC18, respectively. The 800-bp cat cassette was inserted into the plasmid-borne mbl either at its centrally located PstI site (pYA2287), generating pYA2295, or at the KpnI site which is 31 codons from the 3Ј end of the mbl open reading frame (pYA2242), yielding pYA2299. These mbl::cat alleles were then crossed into the chromosome of B. subtilis 168. Introduction of the plasmids pYA2295 or pYA2299 into B. subtilis resulted in Cm r transformants that produced small and normal colony morphologies (Fig. 4) . The small-colony transformants produced colonies of reduced diameter which required a longer incubation time (48 h at 37ЊC on a tryptic soy agar [TSA] plate containing 5 g of chloramphenicol per ml) to appear. The small colonies were generated in greater abundance than were colonies of the normal types, following transformation with either pYA2295 or pYA2299. When cells from either colony type were subcultured on chloramphenicol-containing media, the original colony size was maintained. However, when these strains were restreaked on antibiotic-free TSA, cells of the normal-colony type gave rise only to the normal colonies whereas cells of the small-colony type gave rise to occasional large-colony segregants. These large-colony segregants retained their chloramphenicol resistance.
Because of the apparent growth rate difference between small-and normal-colony types on an agar medium, growth in a liquid medium was also examined. Cultures of KUS1161 (small-colony type) and KUS1162 (normal-colony type) were inoculated into L broth, and their growth was monitored spectrophotometrically. Similar results were obtained with or without the inclusion of chloramphenicol in the broth. Typical results are shown in Fig. 5 . The normal-and small-colony-type transformants grew to a final cell density similar to that of wild-type B. subtilis. The transformants, however, displayed a more pronounced lag phase. This lag was more severe in the small-colony transformants. The growth differences between cells of the normal-and small-colony types is less pronounced than that observed on solid media. This is because each colony arises from a single cell on solid media whereas, in broth cultures, there is only a 500-to 1,000-fold difference in cell concentration from the start to the end of the growth experiment. Consistent with this is the observation that, if the plates bearing the small-colony transformants remain in the 37ЊC incubator beyond 48 h, the small colonies increase in size. This indicates that it is the rate of colony growth, not the ultimate growth potential, which is defective in these transformants.
Genetic basis for colony size variation. Southern blot hybridization analysis was carried out to determine whether allele exchange or Campbell insertion of the plasmids had occurred in the Cm r clones. The probe was plasmid pYA2278 (which contains the PstI-HindIII mbl fragment). Chromosomal DNA from the pYA2295 transformants was digested with HindIII. Plasmid integration would give rise to three hybridizing species, of 3.1, 2.3, and 2.7 kb. Allele replacement would result in the appearance of only one hybridizing band, of 3.1 kb. The hybridization patterns obtained indicated that the small-colony strains consist of cells bearing only the mbl::cat allele (Fig. 3B, lanes 6 and 7) whereas the normal-sized colonies consisted of cells in which the entire plasmid had become integrated into the chromosome (for example, Fig. 3B, lane 8) . The cells producing the normal-sized colonies thus possess the wild-type mbl allele in addition to the inactivated allele, and the wild-type allele is dominant. Chromosomal DNA from transformants obtained with pYA2299 was digested with PstI. In a probe with pYA2278, Campbell insertion of the plasmid would give rise to hybridizing bands of 2.5 and 3.7 kb, whereas allele replacement would result in a single hybridizing species of 2.5 kb. The hybridization patterns obtained indicated that the small-colony strains consisted of cells with only the mbl::cat allele (Fig. 3A, lanes 2, 3, and 5) . Cells of the normal-colony type arise from plasmid integration events (Fig. 3A, lanes 4 and  7) . One example of a large-colony segregant is shown in lane 6 of Fig. 3A . All such segregants retain the mbl::cat allele without any obvious rearrangement or deletion. The segregants thus presumably arise from a second site mutation which restores the growth potential of the mbl mutant. This mutation carried by KUS1165 is designated som-1, for suppressor of mbl.
Phenotype of mbl mutants. The mbl mutant cells remain sporulation proficient. Microscopic examination of the mbl mutant cells displaying the small-colony phenotype revealed a population of bloated, distorted bacilli. The bloated cells had an increased and more irregular diameter than the wild-type cells. The population is heterogeneous in appearance, with some nearly normal cells present along with the distorted cells. These cells are from an actively growing tryptic soy broth culture. An example of cells transformed with pYA2299 is shown in Fig. 6B . Cells of the normal-colony phenotype (mbl ϩ and mbl::cat merodiploids) are wild type in appearance (Fig.  6A) . The aberrant morphology displayed by the mbl mutant cells was evident in the absence of chloramphenicol selection and thus is not an antibiotic-associated artifact. The mbl::cat cells arising from transformation with pYA2295 also displayed the distorted morphology (Fig. 6C) . However, the severity of the distortions was less than that observed with the pYA2299 transformants, despite the fact that the site of the cat insertion was more centrally positioned within mbl. The morphology of the mbl::cat (KpnI) som-1 cells is identical to that of the mutants bearing the PstI site-inactivated mbl allele (data not shown). Thus, the suppressor partially restores the cellular morphology along with its effect on the growth rate of the cells. Introduction of a plasmid-borne copy of mbl into KUS1165 to create a strain which is an mbl-mbl::cat merodiploid in the presence of som-1 resulted in cells with a wild-type phenotype (not shown). Thus, som-1 confers no discernable phenotype on mbl ϩ cells. The pYA2299-transformed mbl::cat cells were subjected to transmission electron microscopy. The population of cells displayed a variety of morphologies, with normal-appearing, bloated, and twisted cells evident in any given field of view. Many of the cells appear twisted into a corkscrew array (Fig.  7A) , whereas others show an increased and irregular cell diameter but are not obviously twisted (Fig. 7B) . The division septa in the dividing cells appear normal (after the cell torsion is taken into account in viewing the cell section), and thus the defect in these cells appears to be wall related rather than septation related.
Expression of the mbl determinant. The mbl determinant is (14, 18, 30) . In order to examine the expression pattern of mbl and to determine whether it is expressed from its own promoter, mbl-lacZ fusions were created. The N terminus of the fusion proteins consisted of 160 amino acids of Mbl joined to the E. coli ␤-galactosidase. The constructs consisted of different amounts of upstream sequences. The 525-bp DraIII-EcoRV fragment contains the mbl ribosome binding site but lacks any additional upstream sequences. The 1-kb DraI-EcoRV fragment contains the spoIIID coding sequence but not its promoter. The 1.8-kb HindIIIEcoRV fragment contains all of spoIIID including its promoter, and the 2.2-kb EcoRV-EcoRV fragment contains all of spoIIID, but with additional sequences upstream of spoIIID. The fusion constructs were introduced in single copy in the B. subtilis chromosome at the amyE locus. The B. subtilis fusion strains were then grown in spI medium (11) , and ␤-galactosidase assays were carried out. The results of these assays are presented in Fig. 8 . No significant amounts of ␤-galactosidase were obtained with strain KUS1199, indicating that the mbl promoter lies upstream of the DraIII site (Fig. 1) . The other fusion constructs all expressed ␤-galactosidase activity. In each case, the activity was greatest in actively growing cells and declined as the cells entered stationary phase. There was no substantial difference in expression pattern in the constructs bearing intact spoIIID elements.
Genetic mapping of the mbl mutant suppressor. When chromosomal DNA was isolated from KUS1165, the large-colony segregant cells, and used to transform wild-type B. subtilis, the majority of transformants were of the small-colony type, indicative of being mbl mutant and som ϩ , with only 3% giving rise to the larger som-1 colonies. PBS-1 transduction experiments indicated that the linkage between som-1 and mbl::cat was 85%. Thus, the second site mutation is genetically linked to, but distinct from, mbl. To map som more precisely, three factor crosses were performed with PBS1 phage grown on KUS1165 donor cells. The results of representative transduction experiments are shown in Table 2 . The som locus maps between hisA and mbl on the B. subtilis chromosome. The implied order is hisA-som-mbl-lssG-tagF.
DISCUSSION
The sequences of mreB determinants have now been reported for three species, E. coli (10) , B. subtilis (20, 32) , and Bacillus cereus (24) . These amino acid sequences show a high degree of similarity, suggestive of a conserved function in these organisms. However, a significant difference between the E. coli and B. subtilis mreBs is the effect of insertional inactivation of mreB on cellular viability. Deletion of E. coli mreB results in viable spherical cells. However, B. subtilis mreB insertional inactivation has thus far been unsuccessful. This disparity can be explained in either of two ways. First, because of the more prominent peptidoglycan layer found in the gram-positive bacterium, loss of MreB function may have a more drastic effect on the wall architecture. Thus, the dependence on MreB may be greater in the gram-positive bacterium. Second, the B. subtilis mreB determinant may not be the true counterpart of E. coli mreB. There is, however, a good reason to believe that mreB is the true homolog of E. coli mreB. The mreB determinant of the divIVB operon of B. subtilis is cotranscribed with mreCD. Thus, the homologs of all three mre genes are similarly organized in the two genera. Additionally, a point mutation in B. subtilis mreD (rodB1) results in the production of spherical cells. Thus, the mreBCD cluster is associated with the maintenance of the rod shape. It is thus functionally homologous to E. coli mreBCD.
On the basis of the amino acid sequence alone, the Mbl protein is a good match to MreB. It aligns with the E. coli MreB protein with the same degree of amino acid identity and similarity as with the B. subtilis MreB protein. Furthermore, the sites of amino acid identities between the two MreB proteins are also the sites of identity with Mbl. However, despite the significant amino acid similarity between Mbl and MreB of B. subtilis, the mbl determinant is unlikely to be mreB. This suggestion is based upon its location on the B. subtilis chromosome and the failure to generate spherical cells, similar to the rodC1 phenotype (32), upon insertional inactivation. Because the function of Mbl appears to be distinct from that of MreB, the amino acid sequence differences between Mbl and MreB may be more informative than the positions of amino acid identity. The conserved nature of the proteins suggests, however, that they may share certain functional or regulatory properties. The B. subtilis Mbl protein displays a much greater sequence identity (86%) with the reported B. cereus MreB protein than it does with the other MreB proteins (Fig. 2) . This high degree of sequence identity to Mbl, coupled with the absence of downstream mreCD determinants, suggests that the sequenced B. cereus determinant is actually the mbl determinant of this bacterium.
Insertional inactivation of mbl resulted in a distortion of the B. subtilis cellular morphology. When the inactivation of mbl occurred at the more central PstI site, the defect in cell morphology was not as pronounced as with the gene inactivated at the KpnI site (close to the 3Ј end of the gene). It is possible that with the PstI site-inactivated allele, the gene inactivated at the middle of the open reading frame, either the mbl allele is not expressed or the truncated mbl protein is rapidly degraded. Thus, the morphological defect may result solely from the lack of this protein. The minor phenotypic effect observed with PstI site-inactivated cells suggests the presence of another gene product(s), compensatory to Mbl. The formation of moreseverely deformed cells with the mbl inactivated at its 3Ј end may be due to the stable expression of the almost-full-length protein. Presumably, this partially truncated protein product is unable to function properly. However, its presence and possession of most of its functional domains could effectively compete with the putative compensatory protein(s), thereby interfering with its activity as well. Merodiploids with both intact and cat-inactivated mbl alleles produce colonies of normal size and cells of a wild-type morphology. Thus, the putative KpnI site-truncated product appears not to be able to compete effectively with the wild-type protein.
The appearance of large-colony segregants from the smallcolony mbl mutants suggests that suppressor mutations which alleviate the growth defect associated with the loss of Mbl function have arisen. The secondary mutations do not map in mbl, which indicates that they are intergenic, rather than intragenic, suppressors. These suppressor mutations should ultimately help define the function of the Mbl protein. There are several possible explanations for the growth rate restoration by the suppressor mutations. (i) The mutation may lie within a gene whose product interacts directly with Mbl. This mutated gene may encode a protein with an altered tertiary structure, which may be able either to function in the absence of Mbl or to interact productively with the truncated Mbl protein.
(ii) The suppressor mutation may alter the activity of a protein or increase the level of its expression, to allow it to substitute more efficiently for Mbl. (iii) The suppressor mutation may inactivate a gene encoding another protein which acts in an Mbl-associated pathway. The loss of this second protein activity may make it more efficient for a compensatory activity to substitute for Mbl. (iv) If Mbl is a protein with a regulatory function, the suppressor mutation might lie within the regulatory region of the Mbl target gene and override the loss of the regulatory molecule. An investigation into the nature of these suppressor mutations should ultimately lead to a more precise understanding of the role of Mbl in the division and shape determination processes in B. subtilis. FIG. 8 . ␤-Galactosidase activities expressed by mbl-lacZ fusions bearing upstream sequences of different extents. Strains KUS1196 to KUS1199 were cultured in spI broth at 37ЊC. Samples were harvested during exponential growth (2 h prior to the onset of stationary phase [TϪ2]), at the onset of stationary phase (T0), and 2 (T2) and 4 (T4) h after the onset of stationary phase. ␤-Galactosidase activity was calculated by the following formula: units ϭ 1,000 ϫ A 420 /A 595 ϫ time (minutes). E, KUS1196; s, KUS1197; }, KUS1198; å, KUS1199. 
